Samsung C&T mulling raising up to $2.8 bln to buy stake in biopharma affiliate: MBC

Alibaba’s Jack Ma urges Facebook to fix privacy issues
April 9, 2018
Uber agrees to buy electric cycle-sharing startup JUMP Bikes
April 9, 2018
This post was originally published on this site

SEOUL (Reuters) – Samsung C&T Corp, de facto holding company of Samsung Group, is considering raising up to 3 trillion won ($2.8 billion) to buy a 30 percent stake in sub-subsidiary Samsung Bioepis Co Ltd, a South Korean TV channel reported on Monday.